Sara González-Rodríguez Selected Research

UCB 35625

5/2017	Hyperalgesic and hypoalgesic mechanisms evoked by the acute administration of CCL5 in mice.
7/2016	Involvement of CC Chemokine Receptor 1 and CCL3 in Acute and Chronic Inflammatory Pain in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sara González-Rodríguez Research Topics

Disease

13	Hyperalgesia 02/2022 - 11/2009
10	Pain (Aches) 02/2022 - 10/2013
6	Inflammation (Inflammations) 01/2021 - 10/2013
5	Neoplasms (Cancer) 10/2020 - 06/2012
3	Cancer Pain 10/2020 - 06/2012
2	Peripheral Nervous System Diseases (PNS Diseases) 02/2022 - 01/2020
2	Melanoma (Melanoma, Malignant) 10/2020 - 06/2012
2	Chronic Pain 01/2018 - 01/2017
2	Bone Neoplasms (Bone Cancer) 01/2014 - 06/2012
2	Osteosarcoma (Osteogenic Sarcoma) 06/2012 - 11/2009
1	Pruritus (Itching) 01/2021
1	Neuroblastoma 01/2019
1	Pathologic Processes 01/2018
1	Migraine Disorders (Migraine) 01/2018
1	Constipation 01/2017
1	Rheumatoid Arthritis 01/2017
1	Experimental Arthritis 01/2017
1	Arthritis (Polyarthritis) 01/2017
1	Neuralgia (Stump Neuralgia) 11/2012
1	Fibrosarcoma 11/2009
1	Neoplastic Processes 11/2009

Drug/Important Bio-Agent (IBA)

6	Analgesics (Analgesic Drugs)IBA 10/2021 - 11/2009
4	Opioid Receptors (Opioid Receptor)IBA 01/2017 - 06/2012
3	Freund's AdjuvantIBA 01/2019 - 06/2016
3	Morphine (MS Contin)FDA LinkGeneric 01/2017 - 06/2012
3	RS 504393IBA 06/2016 - 11/2012
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2022 - 01/2020
2	LigandsIBA 10/2020 - 07/2016
2	N-methylnaloxoneIBA 10/2020 - 01/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 05/2017
2	D-Ala-peptide T-amideIBA 01/2020 - 05/2017
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2018 - 06/2016
2	UCB 35625IBA 05/2017 - 07/2016
2	CytokinesIBA 01/2017 - 10/2013
2	EnkephalinsIBA 01/2017 - 11/2009
2	Opioid Analgesics (Opioids)IBA 01/2017 - 01/2017
2	CarrageenanIBA 07/2016 - 06/2016
2	ChemokinesIBA 06/2016 - 11/2012
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2014 - 11/2012
1	LactamsIBA 02/2022
1	Interleukin-16 (Interleukin 16)IBA 02/2022
1	EndocannabinoidsIBA 12/2021
1	Cyclic PeptidesIBA 10/2021
1	2- ((4- hydroxy- 2- iodo- 5- methoxybenzyl)amino)- 2- oxoethyl dodecanoateIBA 01/2021
1	mu Opioid Receptors (mu Opioid Receptor)IBA 10/2020
1	Fentanyl (Sublimaze)FDA LinkGeneric 10/2020
1	Naloxone (Narcan)FDA LinkGeneric 10/2020
1	Okadaic AcidIBA 01/2019
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2019
1	Menthol FDA Link 01/2019
1	Capsaicin (Zostrix)FDA Link 01/2019
1	Neuroprotective AgentsIBA 01/2019
1	Ion Channels (Ion Channel)IBA 01/2018
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2018
1	Gonadal HormonesIBA 01/2018
1	CCR5 Receptors (CCR5 Receptor)IBA 05/2017
1	ProstaglandinsIBA 05/2017
1	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 05/2017
1	SC 560IBA 05/2017
1	capsazepineIBA 05/2017
1	Celecoxib (Celebrex)FDA Link 05/2017
1	Diclofenac (SR 38)FDA LinkGeneric 05/2017
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2017
1	PL265IBA 01/2017
1	EnzymesIBA 01/2017
1	AutoantibodiesIBA 01/2017
1	Neprilysin (Neutral Endopeptidase)IBA 01/2017
1	AntigensIBA 01/2017
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 01/2017
1	Opioid Peptides (Opioid Peptide)IBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2017
1	CCR ReceptorsIBA 07/2016
1	CCR1 ReceptorsIBA 07/2016
1	CCR2 ReceptorsIBA 06/2016
1	Messenger RNA (mRNA)IBA 01/2014
1	Interleukin-4 (Interleukin 4)IBA 10/2013
1	Calcium Channels (Calcium Channel)IBA 11/2012
1	Chemokine ReceptorsIBA 11/2012
1	tertiapinIBA 06/2012
1	Proteins (Proteins, Gene)FDA Link 06/2012
1	A-317491IBA 11/2009

Therapy/Procedure

6	Analgesia 02/2022 - 06/2012